Rochon Genova and Thomson Rogers filed a class action in Ontario Superior Court against Allergan on behalf of Canadian patients with Biocell breast implants, alleging that Allergan knew about serious health risks — including breast implant-associated anaplastic large cell lymphoma — but failed to adequately warn patients. Vincent Genova, partner at Rochon Genova, noted that Canadian patients have a right to be fully informed about all risks associated with medical devices.
Canadian Class Action Commenced Against Allergan for Breast Implant Risks
